Alimera Sciences (NASDAQ:ALIM) Coverage Initiated by Analysts at StockNews.com
StockNews.com assumed coverage on shares of Alimera Sciences (NASDAQ:ALIM – Free Report) in a report published on Friday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reaffirmed a buy rating and set a $5.00 price target on shares of Alimera Sciences in a report on Monday, August 14th. […]